In this study, the investigators will deliver self-sampling human papillomavirus (HPV)
tests and fecal immunochemical test (FIT) kits, as well as adapted cancer screening
educational materials, by mail to 110 women who are out-of-date for both cervical and
colorectal cancer screenings, recruited through federally qualified health centers
(FQHCs) in rural, segregated counties of Pennsylvania.
The hypothesis is that delivering self-sampling HPV tests and FIT, as well as adapted
educational materials, to women in rural, segregated areas could help increase cancer
screening, reduce geographic cancer disparities, and improve public health.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT04471194.
Locations matching your search criteria
United States
Pennsylvania
Hershey
Penn State Milton S Hershey Medical CenterStatus: Enrolling By Invitation
Name Not Available
In this study, the investigators will deliver self-sampling human papillomavirus (HPV)
tests and fecal immunochemical test (FIT) kits, as well as adapted cancer screening
educational materials, by mail to 110 women who are out-of-date for both cervical and
colorectal cancer screenings, recruited through federally qualified health centers
(FQHCs) in rural, segregated counties of Pennsylvania. A control group of 110 women, also
recruited through FQHCs in rural, segregated counties of Pennsylvania, will be used for
comparison; these women will receive standard-of-care reminders for cancer screening and
complete the baseline and follow-up surveys.
The hypothesis is that delivering self-sampling HPV tests and FIT, as well as adapted
educational materials, to women in rural, segregated areas could help increase cancer
screening, reduce geographic cancer disparities, and improve public health.
Trial PhaseNo phase specified
Trial Typescreening
Lead OrganizationPenn State Milton S Hershey Medical Center
